Tag: common warts market forecast

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Common Warts Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market size for common warts has seen substantial growth in the past few years. It is projected to increase from $2.13 billion in 2024 to $2.25 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%. Factors contributing to this growth during the historic period include elevated consciousness about skin health, a rise in the occurrence of warts, growing preference for non-invasive processes, upsurge in the utilization of cryotherapy, and expansion of dermatology clinics.

In the forthcoming years, the market for common warts is set to experience robust growth. The predictions reveal an expansion to$2.81 billion by 2029, with a compound annual growth rate (CAGR) of 5.7%. Factors such as the increasing elderly population, heightened occurrence of viral infections, widened acceptance of sophisticated dermatological treatments, rising demand for customized remedies, and a stronger consumer inclination towards homecare solutions converge to drive growth in the projected period. The period also expects to witness certain trends like the evolution in dermatological treatments, growth in healthcare infrastructure, advancements in technology used for the removal of warts, increased knowledge regarding treatment choices, and a lean towards minimally invasive treatments.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp

What Are the Core Growth Drivers Propelling the Common Warts Market Forward?

As the prevalence of viral infections increases, it is anticipated that this will drive the expansion of the common warts market. A viral infection is characterized by the entry, proliferation, and spread of viruses within the human body which subsequently affects cellular function and immune responses. Factors such as globalization, changes in climate, urbanization, deforestation, and weakened immune systems contribute to the rising incidence of these infections. The treatment of common warts primarily focuses on addressing the human papillomavirus (HPV), the virus responsible for causing warts. Such treatment helps patients with viral infections by curtailing the virus’s spread, easing discomfort, and promoting healing, thus averting complications like secondary infections or scarring, concurrently enhancing patient’s quality of life. For example, the Centers for Disease Control and Prevention, a US government agency, stated in 2024 that the percentage of PCR-confirmed varicella cases had surged by 62%, from 29% to 47% in the last five years as of 2022. The National Foundation for Infectious Diseases, another US health organization, added, in January 2023, that approximately 14 million new instances of HPV infection emerge annually in the US. Hence, the growing rate of viral infections is fueling the growth of the common warts market.

What Segment Types Define the Common Warts Market Structure?

The common wartsmarket covered in this report is segmented –

1) By Treatment Method: Cryotherapy; Laser Treatment; Electrosurgery; Topical Medications

2) By Patient Demographics: Children; Adults; Elderly

3) By Disease Stage: Initial Stage; Moderate Stage; Severe Stage

4) By End User: Hospitals; Dermatology Clinics; Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy; Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy; Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal; High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy; Immunotherapy-Based Topicals; Retinoid-Based Therapy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21154&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Common Warts Market?

North America was the largest region in the common warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing theCommon Warts Industry Evolution?

Major corporations active in the common warts market are shifting their focus towards the progression of novel treatments like dermatological therapies in order to meet increasing need for effective and easily accessible remedies. They aim to enhance patient outcomes and broaden their scope within the dermatological sector. Treatments for skin conditions including infections, inflammations and disorders are encapsulated by dermatological therapies. For example, in May 2024, an agreement was formed between Verrica Pharmaceuticals from the U.S., and Torii Pharmaceutical Co. Ltd. From Japan. The partnership was formed with the objective to sponsor global Phase 3 clinical trial for YCANTH, a cure for common warts. The contract permits the late-stage development of YCANTH thus enlarging its likely global reach. Torii Pharmaceuticals will provide monetary support to facilitate the research. The partnership enriches both corporations’ dermatological product range and international market standing.

View the full report here:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

What Is the Definition of the Common Warts Market?

Common warts are non-cancerous skin growths caused by the human papillomavirus (HPV). They typically appear on the hands, fingers, and other areas, serving as a defense mechanism for the body in response to the viral infection.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21154

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Common Warts Market Size Changed, over the years?

The market size for common warts has seen robust growth in the past few years. It is projected to rise from $2.13 billion in 2024 to $2.26 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. The historical growth can be correlated with the heightened awareness of skin health, a surge in the prevalence of warts, an escalating demand for non-invasive procedures, an increased uptake of cryotherapy, and the expansion of dermatology clinics.

How Much Will the Common Warts Market Be Worth in 2029?

The market for common warts is projected to experience substantial growth in the near future, expected to surge to $2.83 billion in 2029, advancing at a compound annual growth rate (CAGR) of 5.8%. This anticipated growth during the forecast period is primarily due to reasons such as the growing elderly population, increasing instances of viral infections, higher uptake of progressive dermatological therapies, burgeoning demand for customized treatments, and a rising inclination towards homecare solutions among consumers. Key trends set to shape the market in the forecast timeframe encompass advancements in dermatological treatments, a burgeoning healthcare infrastructure, technological innovation in wart elimination therapies, improved awareness regarding treatment alternatives, and a transition towards minimally invasive treatments.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp

Which is the Largest Company in the Common Warts Market?

Major companies operating in the common warts market are Major players in the market are AbbVie Inc., GlaxoSmithKline plc, Sun Pharmaceutical Industries Limited, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Maruho Co. Ltd., Novan Inc., X4 Pharmaceuticals Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., RXi Pharmaceuticals Corporation, Scholl’s Wellness Company, Nielsen BioSciences Inc., Cassiopea S.p.A., Orgenesis Inc., KinoPharma Inc., Naturasil, Veradermics Inc., KinoPharma Co. Ltd.

What Are the Main Market Drivers in the Common Warts Industry?

The prevalence of viral infections is anticipated to boost the expansion of the common warts market. Viral infections denote diseases brought about by the invasion, propagation, and dissemination of viruses within the human body, which affects cells and the immune system. Factors like globalization, urbanization, climate change, deforestation, and impaired immune responses contribute to the rise of these infections. Targeted treatment for common warts focuses on the human papillomavirus (HPV), the virus that causes wart development, and brings critical relief to patients with viral infections by mitigating virus transmission, alleviating discomfort, and facilitating healing, thereby averting potential issues like secondary infections or scarring and enhancing the patient’s life quality. To exemplify, the Centers for Disease Control and Prevention, a legislated agency in the US, reported that between 2019 and 2024, PCR-confirmed varicella cases surged by 62% from 29% to 47%. Additionally, as per the data from the National Foundation for Infectious Diseases, another health-related organization in the US, it’s estimated that there are approximately 14 million new instances of HPV infection every year in the United States. Thus, the escalating prevalence of viral infections is fuelling the growth of the common warts market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=21154&type=smp

How Is the Common Warts Market Segments Structured?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

What Strategic Trends Are Transforming the Common Warts Market?

Leading firms in the common warts market are zeroing in on progressive cutting-edge treatments like dermatological therapies to answer to the escalating needs for effective and readily available solutions. These efforts are aimed at improving patient results and broadening their market footprint in the dermatology sector. Dermatological solutions are treatments targeting skin conditions that include infections, inflammations, and disorders. For example, in May 2024, a US-based company, Verrica Pharmaceuticals, struck a licensing deal with Torii Pharmaceutical Co. Ltd., which is located in Japan. The partnership is geared toward financing a global Phase 3 clinical trial for YCANTH, a common warts treatment. This deal propels the late-stage development of YCANTH, broadening its possible global impact. Torii Pharmaceuticals will provide the financial backing needed to drive the study forward. This allows both corporations to strengthen their dermatology offerings and boost their global market presence.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

Which Global Regions Offer the Highest Growth in the Common Warts Market?

North America was the largest region in the common warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21154

This Report Delivers Insight On:

1. How big is the common warts market, and how is it changing globally?

2. Who are the major companies in the common warts market, and how are they performing?

3. What are the key opportunities and risks in the common warts market right now?

4. Which products or customer segments are growing the most in the common warts market?

5. What factors are helping or slowing down the growth of the common warts market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Are the Projected Market Size and Growth Rates for the Common Warts Market From 2025 To 2029?

The market size for common warts has seen a significant surge in recent years. It is forecasted to escalate from $2.13 billion in 2024 to $2.26 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.2%. Factors contributing to the growth during the historical period include a heightened awareness of skin health, an increase in wart cases, a surge in preference for non-invasive techniques, wider adoption of cryotherapy, and an expansion in dermatology clinics.

The market size for common warts is set to experience substantial growth in the upcoming years, and it’s predicted to reach the value of $2.83 billion by 2029, with a 5.8% compound annual growth rate (CAGR). The expansion during the forecasted period can be linked to factors such as an increasing aged population, a rise in viral infections, the broadening application of sophisticated dermatological therapies, strong demand for individualized treatments, and a growing trend of homecare solutions among consumers. Key trends expected to shape this period encompass improvements in dermatological treatments, augmentation of healthcare infrastructure, technological progression in wart removal techniques, heightened treatment options awareness, and a transition toward less invasive treatments.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Common Warts Market?

The rise in viral infections is projected to spur the expansion of the common warts market. Viral infections are diseases that result from the entry, multiplication, and dissemination of viruses within the human body, thereby affecting cells and immune responses. The surge in viral infections can be attributed to factors such as globalization, climatic changes, urbanization, deforestation, and compromised immune responses. The treatment for common warts aims to eliminate the human papillomavirus (HPV), which causes wart formation, and offers critical aid for patients with viral infections by decreasing viral spread, mitigating discomfort, and fostering healing. This helps avert potential complications like secondary infections or scars and enhances the patient’s lifestyle. For instance, the Centers for Disease Control and Prevention, a US government agency, reported in 2024 that the ratio of PCR-confirmed varicella cases had escalated by 62%, rising from 29% to 47% during the preceding five years in 2022. Moreover, as per the National Foundation for Infectious Diseases, a US health agency, it was reported in January 2023 that annually, there are approximately 14 million fresh cases of HPV infection in the United States. Consequently, the escalating rate of viral infections is stimulating growth in the common warts market.

Which Primary Segments of the Common Warts Market Are Driving Growth and Industry Transformations?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21154&type=smp

Which Regions Are Key Players in the Growth of the What Are the Primary Drivers Supporting the Market Growth of the Common Warts Market? Market?

North America was the largest region in the common warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Common Warts Market?

The principal businesses in the common warts market are directing their attention towards the progression of novel treatments such as dermatological therapies, with the objective of fulfilling the increasing need for efficient and obtainable solutions. This aims to enhance the results for patients and broadens their market footprint in the dermatology division. Dermatological therapies are used as treatments for various skin conditions such as infections, inflammations and disorders. Verrica Pharmaceuticals, a pharmaceutical firm based in the United States, went into a licensing agreement with Torii Pharmaceutical Co. Ltd., a pharmaceutical business from Japan in May 2024. The goal of this partnership is to provide funds for a global Phase 3 clinical trial for YCANTH, a treatment intended for common warts. This agreement propels the late-stage development of YCANTH and boosts its possible worldwide reach. Torii Pharmaceuticals will provide financial support to push the study’s progression. This partnership fortifies the international dermatology portfolios and market presence of both companies.

View the full report here:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

What Parameters Are Used to Define the Common Warts Market?

Common warts are non-cancerous skin growths caused by the human papillomavirus (HPV). They typically appear on the hands, fingers, and other areas, serving as a defense mechanism for the body in response to the viral infection.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21154

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Common Warts Market?

The increasing incidence of viral infections is driving growth in the common warts market. Viral infections, including those caused by human papillomavirus (HPV), are becoming more common due to factors like globalization and weakened immune responses. Common warts, caused by HPV, require treatment to reduce viral spread, alleviate discomfort, and promote healing. According to the Centers for Disease Control and Prevention (CDC), the incidence of varicella (chickenpox) has increased by 62% in the last five years, and HPV infections continue to rise with an estimated 14 million new cases annually in the U.S. These trends are fueling the demand for treatments to manage common warts.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp

What is the Predicted Annual Growth Rate of theCommon Warts Market Impact Industry Trends by 2034?

The common warts market has also seen steady expansion. It is expected to grow from $2.13 billion in 2024 to $2.26 billion in 2025 at a CAGR of 6.2%. The primary factors driving historical growth include greater awareness of skin health, an increasing number of wart cases, higher demand for non-invasive treatments, greater adoption of cryotherapy, and an expansion of dermatology clinics.

The common warts market is expected to expand significantly, reaching $2.83 billion in 2029 at a CAGR of 5.8%. Growth in this period will be driven by an aging population, increasing viral infection rates, rising adoption of advanced dermatological therapies, growing demand for customized treatments, and a shift towards home-based care solutions. Major trends shaping this market include advancements in dermatological procedures, improvements in healthcare infrastructure, technological progress in wart removal treatments, increased awareness of available options, and the adoption of minimally invasive techniques.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21154

What Are the Most Significant Market Trends Transforming theCommon Warts Market?

In the common warts market, companies are advancing dermatological therapies to meet the growing demand for effective, accessible treatments, aiming to improve patient outcomes and expand their market presence. Dermatological therapies address skin conditions such as infections, inflammations, and disorders. For instance, in May 2024, Verrica Pharmaceuticals, a US-based pharmaceutical company, entered a license agreement with Torii Pharmaceutical Co. Ltd., a Japan-based company. The collaboration will fund a global Phase 3 clinical trial for YCANTH, a treatment for common warts, supporting its development and expansion in global markets. Torii Pharmaceuticals will contribute financial resources to advance the study, enhancing both companies’ dermatology portfolios.

What Are the Top Market Players Propelling the Growth of theCommon Warts Industry?

Major companies operating in the common warts market are Major players in the market are AbbVie Inc., GlaxoSmithKline plc, Sun Pharmaceutical Industries Limited, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Maruho Co. Ltd., Novan Inc., X4 Pharmaceuticals Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., RXi Pharmaceuticals Corporation, Scholl’s Wellness Company, Nielsen BioSciences Inc., Cassiopea S.p.A., Orgenesis Inc., KinoPharma Inc., Naturasil, Veradermics Inc., KinoPharma Co. Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

Which Primary Segments of the Common Warts Market Are Driving Growth and Industry Transformations?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21154&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Common Warts Market?# Market?

North America was the largest region in the common warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Common Warts Market 2025, By The Business Research Company:

Anticonvulsants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anticonvulsants-global-market-report

Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report

Anti-Inflammatory Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the common warts market?

There has been considerable growth in the market size for common warts in past few years. The market, which stands at $2.13 billion in 2024, is projected to escalate to $2.26 billion in 2025, presenting a compound annual growth rate (CAGR) of 6.2%. The upswing in growth during the historic period is the result of heightened understanding of skin health, an increase in warts cases, a surging need for non-invasive procedures, a rise in the utilization of cryotherapy, and expansion of dermatology clinics.

What will be the common warts market size in the future?

The future years are predicted to witness robust expansion in the market size for common warts, with projections pointing to an increase to $2.83 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. Various factors are contributing to this expected growth within the prediction period, including an aging population, increasing cases of viral infections, widespread uptake of advanced skin treatments, growing preference for tailor-made remedies, and a rise in consumer preference for home-based solutions. Noteworthy trends expected within this period encompass developments in skin disease treatments, growth in healthcare infrastructure, advances in techniques for wart removal, improved knowledge of available treatment choices, and a tendency towards less invasive treatments.

Get your common warts market report here!

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

What main drivers are fueling expansion in the common warts market?

The projected growth of the common warts market is expected to be fueled by the rising prevalence of viral infections. Viral infections encompass diseases triggered by the invasion, proliferation and spread of viruses in the body, which often cause cellular damage and disturb immune responses. Factors such as globalization, climate change, urbanization, deforestation, and weakened immunity contribute to the escalating prevalence of these infections. Treatments for common warts typically focus on targeting human papillomavirus (HPV), the pathogen causing wart formation. These treatments aim to control the spread of the virus, ease discomfort, and facilitate healing in patients, while also preventing potential complications like secondary infections or scarring, ultimately improving the patient’s life quality. For example, in 2024, the US-based government agency, Centers for Disease Control and Prevention, reported that the ratio of PCR-verified varicella cases had surged by 62%, moving from 29% to 47% in the last five years. Furthermore, according to the US-based health organization, National Foundation for Infectious Diseases, in January 2023, there are approximately 14 million new instances of HPV infection annually in the United States. Therefore, the escalating prevalence of viral infections is propelling the growth of the common warts market.

What key areas define the segmentation of the global common warts market?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp

Who are the dominant players expanding their reach in the common warts market?

Major companies operating in the common warts market are Major players in the market are AbbVie Inc., GlaxoSmithKline plc, Sun Pharmaceutical Industries Limited, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Maruho Co. Ltd., Novan Inc., X4 Pharmaceuticals Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., RXi Pharmaceuticals Corporation, Scholl’s Wellness Company, Nielsen BioSciences Inc., Cassiopea S.p.A., Orgenesis Inc., KinoPharma Inc., Naturasil, Veradermics Inc., KinoPharma Co. Ltd.

What key trends are currently impacting the common warts market’s development?

Leading businesses in the common warts market are concentrating on developing novel treatments like dermatological therapies. This move is aimed at fulfilling the increasing need for effective and easily accessible solutions, boosting patient outcomes, and broadening their footprint in the dermatology space. Dermatological therapies encompass treatments for various skin conditions such as infections, inflammations, and disorders. For instance, in May 2024, Verrica Pharmaceuticals, a pharmaceutical firm based in the US, entered into a licensing agreement with Torii Pharmaceutical Co. Ltd., a pharmaceutical company headquartered in Japan. The purpose of this alliance is to finance a global Phase 3 clinical trial for YCANTH, a common warts treatment. This partnership aids the advanced-stage development of YCANTH, consequently widening its prospective global penetration. Torii Pharmaceuticals is set to provide financial backing to foster the study. This partnership bolsters the dermatology portfolios of both firms and their presence in the international market.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21154

Which regions are emerging as leaders in the common warts market?

North America was the largest region in the common warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Anticonvulsants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anticonvulsants-global-market-report

Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report

Anti-Inflammatory Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Factors Are Driving the Anticipated Growth Rate of the Common Warts Market Through 2034?

Over the past few years, there has been substantial growth in the market size for common warts. Predictions indicate an increase from $2.13 billion in 2024 to $2.26 billion in 2025, presenting a compound annual growth rate (CAGR) of 6.2%. The historical growth has been motivated by a heightened consciousness of skin health, a higher occurrence of warts, surging needs for non-surgical methods, alongside an amplified use of cryotherapy. Additionally, the proliferation of dermatology clinics added to this expansion.

The market size for common warts is projected to witness significant growth in the coming years. It is expected to reach a value of $2.83 billion in 2029, with an annual compound growth rate (CAGR) of 5.8%. The predicted growth during this period can be linked to factors such as the increasing elderly population, the rising prevalence of viral infections, and the growing uptake of advanced dermatological therapies. Moreover, there is an increasing need for personalized treatments and a preference for homecare solutions amongst consumers. Key trends for the forecast period include advancements in dermatological treatments, the expansion of healthcare infrastructure, technological innovation in wart removal therapies, increased knowledge about different treatment options, and a transition towards less invasive treatments.

Which Factors Are Enhancing the Growth of the Common Warts Market?

The continuous surge in viral infections is anticipated to stimulate the expansion of the common warts market in the future. Viral infections characterize sicknesses that result from viruses infiltrating, proliferating, and disseminating within the body, affecting cells and the immune system. This surge in viral infections can be attributed to globalization, climate fluctuations, urbanization, deforestation, and compromised immune responses. The overarching aim of common warts treatment is to target the human papillomavirus (HPV), which is the culprit behind wart development. The treatment offers vital support to patients suffering from viral infections by decreasing the virus’s transmission, easing discomfort, and encouraging healing, thereby averting potential complications like secondary infections or scarring and enhancing the patient’s lifestyle quality. For example, the US government agency, Centers for Disease Control and Prevention, reported a 62% increase in PCR-confirmed varicella cases in 2022, escalating from 29% to 47% in the last five years as of 2024. Additionally, the National Foundation for Infectious Diseases, a US health organization, reported in January 2023 that there are approximately 14 million fresh HPV infection cases each year in the United States. Consequently, the surge in viral infections propels the common warts market’s growth.

Get Your Free Sample of the Global Common Warts Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp

Who are the major industry leaders accelerating growth in the Common Warts market?

Major companies operating in the common warts market are Major players in the market are AbbVie Inc., GlaxoSmithKline plc, Sun Pharmaceutical Industries Limited, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Maruho Co. Ltd., Novan Inc., X4 Pharmaceuticals Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., RXi Pharmaceuticals Corporation, Scholl’s Wellness Company, Nielsen BioSciences Inc., Cassiopea S.p.A., Orgenesis Inc., KinoPharma Inc., Naturasil, Veradermics Inc., KinoPharma Co. Ltd.

Which Current Trends Are Having the Most Impact on the Common Warts Market?

Big players in the common warts market are concentrating their efforts on developing innovative treatments, such as dermatological therapies, in order to meet the increasing demand for effective and accessible solutions. Their end goal is to enhance patient wellbeing and broaden their reach in the dermatology industry. Dermatological therapies, in this context, imply treatments for various skin conditions like infections, inflammations, and disorders. For example, in May 2024, Verrica Pharmaceuticals, an American pharmaceutical firm, joined hands with Torii Pharmaceutical Co. Ltd., a Japanese pharmaceutical company, in a licensing agreement. The purpose of this association is to finance a worldwide Phase 3 clinical trial for YCANTH, intended for treating common warts. This partnership facilitates the later development stages of YCANTH and extends its anticipated global reach. Torii Pharmaceuticals will provide monetary support to propel the study forward. This alliance bolsters the dermatology portfolios of both firms and boosts their international presence in the market.

Get Instant Access to the Global Common Warts Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

What Are the Major Categories and Their Growth Dynamics in the Common Warts Market?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

Which Regions Are Key Players in the Growth of the Common Warts Market?

North America was the largest region in the common warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Elements Shape the Definition of the Common Warts Market?

Common warts are non-cancerous skin growths caused by the human papillomavirus (HPV). They typically appear on the hands, fingers, and other areas, serving as a defense mechanism for the body in response to the viral infection.

Browse Through More Similar Reports By The Business Research Company:

Anticonvulsants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anticonvulsants-global-market-report

Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report

Anti-Inflammatory Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: